Oncopeptides AB (publ)

SSE:ONCO.ST

7.264 (SEK) • At close February 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) SEK.

2023202220212020201920182017201620152014
Assets:
Current Assets:
Cash & Cash Equivalents 173.407344.515362.187840.255926.186375.617404.0540.2512.29311.966
Short Term Investments 0.0320.3482.11212.2270-0.85-0.262-0.26200
Cash and Short Term Investments 173.407344.515362.187840.255926.186375.617404.0540.2512.29311.966
Net Receivables 27.06817.26837.99823.2296.9762.4561.1892.96300.047
Inventory 2.425008.6650-2.45671.983-2.96300
Other Current Assets -02.251-0.00122.6537.72665.699-0.00114.018-0.0010.979
Total Current Assets 202.9364.034412.373894.799970.888441.316477.22154.2694.23112.944
Non-Current Assets:
Property, Plant & Equipment, Net 34.62620.43824.74438.3317.1922.3632.3391.10.0070.015
Goodwill 0000000000
Intangible Assets 001.4081.832.11100000
Goodwill and Intangible Assets 001.4081.832.11100000
Long Term Investments 0.8520.8510.8513.6221.0350.8510.2630.26300
Tax Assets 00-0.8518.1752.26200000
Other Non-Current Assets -00-26.152000-0.00100.1640.163
Total Non-Current Assets 35.47821.28927.00351.95722.63.2142.6011.3630.1710.178
Total Assets 238.378385.323439.376946.756993.488444.53479.82255.6334.40213.123
Liabilities & Equity:
Current Liabilities:
Account Payables 15.02528.21935.702136.13580.98625.2715.6818.7315.1152.568
Short Term Debt 5.1315.99910.98712.4266.65200000
Tax Payables 0.5796.7787.02514.245.4784.0560.95400.1860
Deferred Revenue 0.50128.681197.4677.35300000
Other Current Liabilities 24.27751.45449.9198.3790.18988.5744.31220.5651.8872.949
Total Current Liabilities 44.93385.672225.289354.4165.18113.8459.99329.2967.0025.517
Non-Current Liabilities:
Long Term Debt 106.4873.5433.2066.9298.24300000
Deferred Revenue Non-Current 0000000000
Deferred Tax Liabilities Non-Current 0000000000
Other Non-Current Liabilities 30.1781.8150.0138.5323.05214.8581.824000
Total Non-Current Liabilities 136.6655.3583.21915.45931.29514.8581.824000
Total Liabilities 181.59891.03228.508369.859196.475128.69861.81729.2967.0025.517
Equity:
Preferred Stock 5,355.4762.2970.9181.542000000
Common Stock 10.51110.4798.3667.5496.1574.8994.4232.4492.0461.506
Retained Earnings -5,365.987-5,116.414-4,778.463-3,348.146-1,753.452-961.919-542.462-294.85-180.405-127.064
Accumulated Other Comprehensive Income/Loss 46.269-2.297-0.918-1.5420.0020.0220000
Other Total Stockholders Equity 10.5115,400.2284,980.9653,917.4942,544.3061,272.83956.044318.738175.759133.163
Total Shareholders Equity 56.78294.293210.868576.897797.013315.832418.00526.337-2.67.606
Total Equity 56.78294.293210.868576.897797.013315.832418.00526.337-2.67.606
Total Liabilities & Shareholders Equity 238.378385.323439.376946.756993.488444.53479.82255.6334.40213.123